117.5430 CanSino Biologics (simplified Chinese: 康希诺生物; traditional Chinese: 康希諾生物; pinyin: Kāngxīnuò Shēngwù), often abbreviated as CanSinoBIO, is a Chinese...

COVID-19 that is also used as an inhaled booster. It was developed by CanSino Biologics, with Phase III trials conducted in Argentina, Chile, Mexico, Pakistan...

Uyghurs in China. During the COVID-19 pandemic, the AMMS partnered with CanSino Biologics to develop Convidecia. The development team, led by Chen Wei, registered...

Institute of Biotechnology, the Academy of Military Medical Sciences, and CanSino Biologics to develop Convidecia. The development team registered a Phase 1 trial...

COVID-19 vaccine is also an inactivated virus vaccine.[citation needed] CanSino Biologics Sinovac "中国医药集团有限公司主要领导调整" (in Chinese). Sinopharm. Archived from...

October 2022, China began administering an oral vaccine developed by CanSino Biologics using its adenovirus model. Despite the availability of mRNA and viral...

reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5...

Sputnik V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development...

authorizes use of China's CanSino vaccine against COVID-19". Reuters. 15 June 2021. Retrieved 16 June 2021. "China's CanSino Biologics COVID-19 vaccine receives...

(NASDAQ:ZLAB; HKSE:9688), CanSino Biologics(SSE:688185; HKSE:6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar...